Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

Mes dernières consult.
Most popular
Analysis summary4-Traders Strategies

Anaïs Lozach

share with twitter share with LinkedIn share with facebook
share via e-mail

The underlying trend is to the upside

Strategy published on 06/12/2017 | 14:42
long trade
Target price hit
Entry price : 131.61$ | Target : 136$ | Stop-loss : 128.9$ | Potential : 3.34%
Johnson & Johnson shares show a positive technical situation which suggests a continuation of the upward dynamic over the medium term.
Investors have an opportunity to buy the stock and target the $ 136.
  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
  • Within the weekly time frame the stock shows a bullish technical configuration above the support level at 121.76 USD

  • The share is close to its long-term resistance in weekly data. Therefore, the potential should be limited. However, a further bullish movement when crossing this resistance will be a positive signal.
  • Based on current prices, the company has particularly high valuation levels.
share with twitter share with LinkedIn share with facebook
share via e-mail

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials ($)
Sales 2018 81 115 M
EBIT 2018 24 940 M
Net income 2018 19 683 M
Debt 2018 12 439 M
Yield 2018 2,88%
P/E ratio 2018 17,37
P/E ratio 2019 16,30
EV / Sales 2018 4,29x
EV / Sales 2019 3,95x
Capitalization 336 B
Surperformance© ratings
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Earnings quality
Business Predictability
P/E ratio
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
Bollinger Spread
Unusual Volumes
Duration : Period : Day
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | 4-Traders
Duration : Period : Week
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | 4-Traders